|
1
|
Tachibana K, Hirota S, Iizasa H, Yoshida
H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N,
Nishikawa S, et al: The chemokine receptor CXCR4 is essential for
vascularization of the gastrointestinal tract. Nature. 393:591–594.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagasawa T, Hirota S, Tachibana K,
Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H and
Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow
myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature.
382:635–638. 1996. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zou YR, Kottmann AH, Kuroda M, Taniuchi I
and Littman DR: Function of the chemokine receptor CXCR4 in
haematopoiesis and in cerebellar development. Nature. 393:595–599.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Askari AT, Unzek S, Popovic ZB, Goldman
CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD,
DiCorleto PE, et al: Effect of stromal-cell-derived factor 1 on
stem-cell homing and tissue regeneration in ischaemic
cardiomyopathy. Lancet. 362:697–703. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jujo K, Ii M, Sekiguchi H, Hamada H,
Thorne T, Klyachko E, Clarke T, Ito A, Misener S, Renault MA and
Losordo DW: Bone marrow MMP-9 expression mediates therapeutic
effect of selective CXCR4 antagonist AMD3100 on myocardial
infarction. Circulation. 118:S536–S537. 2008.
|
|
6
|
Marin-Juez R, El-Sammak H, Helker CSM,
Kamezaki A, Mullapuli ST, Bibli SI, Foglia MJ, Fleming I, Poss KD
and Stainier DYR: Coronary revascularization during heart
regeneration is regulated by epicardial and endocardial cues and
forms a scaffold for cardiomyocyte repopulation. Dev Cell.
51:503–515.e504. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang FY, Xia TL, Li JL, Li CM, Zhao ZG,
Lei WH, Chen L, Liao YB, Xiao D, Peng Y, et al: The bifunctional
SDF-1-AnxA5 fusion protein protects cardiac function after
myocardial infarction. J Cell Mol Med. 23:7673–7684. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abbott JD, Huang Y, Liu D, Hickey R,
Krause DS and Giordano FJ: Stromal cell-derived factor-1alpha plays
a critical role in stem cell recruitment to the heart after
myocardial infarction but is not sufficient to induce homing in the
absence of injury. Circulation. 110:3300–3305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng M, Zhou J, Wu M, Boriboun C, Thorne
T, Liu T, Xiang Z, Zeng Q, Tanaka T, Tang YL, et al: CXCR4-mediated
bone marrow progenitor cell maintenance and mobilization are
modulated by c-kit activity. Circ Res. 107:1083–1093. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang YL, Zhu W, Cheng M, Chen L, Zhang J,
Sun T, Kishore R, Phillips MI, Losordo DW and Qin G: Hypoxic
preconditioning enhances the benefit of cardiac progenitor cell
therapy for treatment of myocardial infarction by inducing CXCR4
expression. Circ Res. 104:1209–1216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saxena A, Fish JE, White MD, Yu S, Smyth
JWP, Shaw RM, DiMaio JM and Srivastava D: Stromal cell-derived
factor-1alpha is cardioprotective after myocardial infarction.
Circulation. 117:2224–2231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Segers VF, Tokunou T, Higgins LJ,
MacGillivray C, Gannon J and Lee RT: Local delivery of
protease-resistant stromal cell derived factor-1 for stem cell
recruitment after myocardial infarction. Circulation.
116:1683–1692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J,
Guo Y, Bolli R and Rokosh G: Stromal cell derived factor-1 alpha
confers protection against myocardial ischemia/reperfusion injury:
Role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis.
Circulation. 116:654–663. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bromage DI, Taferner S, He Z, Ziff OJ,
Yellon DM and Davidson SM: Stromal cell-derived factor-1alpha
signals via the endothelium to protect the heart against
ischaemia-reperfusion injury. J Mol Cell Cardiol. 128:187–197.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiong H, Luo Y, Yue Y, Zhang J, Ai S, Li
X, Wang X, Zhang YL, Wei Y, Li HH, et al: Single-cell
transcriptomics reveals chemo-taxis-mediated intraorgan crosstalk
during cardiogenesis. Circ Res. 125:398–410. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Segret A, Rucker-Martin C, Pavoine C,
Flavigny J, Deroubaix E, Châtel MA, Lombet A and Renaud JF:
Structural localization and expression of CXCL12 and CXCR4 in rat
heart and isolated cardiac myocytes. J Histochem Cytochem.
55:141–150. 2007. View Article : Google Scholar
|
|
17
|
Pyo RT, Sui J, Dhume A, Palomeque J,
Blaxall BC, Diaz G, Tunstead J, Logothetis DE, Hajjar RJ and
Schecter AD: CXCR4 modulates contractility in adult cardiac
myocytes. J Mol Cell Cardiol. 41:834–844. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
LaRocca TJ, Altman P, Jarrah AA, Gordon R,
Wang E, Hadri L, Burke MW, Haddad GE, Hajjar RJ and Tarzami ST:
CXCR4 cardiac specific knockout mice develop a progressive
cardiomyopathy. Int J Mol Sci. 20:22672019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Damas JK, Eiken HG, Oie E, Bjerkeli V,
Yndestad A, Ueland T, Tonnessen T, Geiran OR, Aass H, Simonsen S,
et al: Myocardial expression of CC- and CXC-chemokines and their
receptors in human end-stage heart failure. Cardiovasc Res.
47:778–787. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Gareri C and Rockman HA:
G-protein-coupled receptors in heart disease. Circ Res.
123:716–735. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Lucia C, Eguchi A and Koch WJ: New
insights in cardiac β-adrenergic signaling during heart failure and
aging. Front Pharmacol. 9:9042018. View Article : Google Scholar
|
|
22
|
Packer M, Carver JR, Rodeheffer RJ,
Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U
and Kukin ML: Effect of oral milrinone on mortality in severe
chronic heart failure. The PROMISE study research group. N Engl J
Med. 325:1468–1475. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shizukuda Y, Buttrick PM, Geenen DL,
Borczuk AC, Kitsis RN and Sonnenblick EH: Beta-adrenergic
stimulation causes cardiocyte apoptosis: Influence of tachycardia
and hypertrophy. Am J Physiol. 275:H961–H968. 1998.PubMed/NCBI
|
|
24
|
Asai K, Yang GP, Geng YJ, Takagi G, Bishop
S, Ishikawa Y, Shannon RP, Wagner TE, Vatner DE, Homcy CJ and
Vatner SF: Beta-adrenergic receptor blockade arrests myocyte damage
and preserves cardiac function in the transgenic G(salpha) mouse. J
Clin Invest. 104:551–558. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu WZ, Wang SQ, Chakir K, Yang D, Zhang
T, Brown JH, Devic E, Kobilka BK, Cheng H and Xiao RP: Linkage of
beta1-adrenergic stimulation to apoptotic heart cell death through
protein kinase A-independent activation of Ca2+/calmodulin kinase
II. J Clin Invest. 111:617–625. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Whelan RS, Konstantinidis K, Xiao RP and
Kitsis RN: Cardiomyocyte life-death decisions in response to
chronic beta-adrenergic signaling. Circ Res. 112:408–410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Packer M, Bristow MR, Cohn JN, Colucci WS,
Fowler MB, Gilbert EM and Shusterman NH: The effect of carvedilol
on morbidity and mortality in patients with chronic heart failure.
U.S. Carvedilol heart failure study group. N Engl J Med.
334:1349–1355. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Szeto C, Gao E, Tang M, Jin J, Fu
Q, Makarewich C, Ai X, Li Y, Tang A, et al: Cardiotoxic and
cardioprotective features of chronic β-adrenergic signaling. Circ
Res. 112:498–509. 2013. View Article : Google Scholar
|
|
29
|
Singh K, Xiao L, Remondino A, Sawyer DB
and Colucci WS: Adrenergic regulation of cardiac myocyte apoptosis.
J Cell Physiol. 189:257–265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Adams JW and Brown JH: G-proteins in
growth and apoptosis: Lessons from the heart. Oncogene.
20:1626–1634. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Steinberg SF: Beta1-adrenergic receptor
regulation revisited. Circ Res. 123:1199–1201. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rohrer DK, Desai KH, Jasper JR, Stevens
ME, Regula DP Jr, Barsh GS, Bernstein D and Kobilka BK: Targeted
disruption of the mouse beta1-adrenergic receptor gene:
Developmental and cardiovascular effects. Proc Natl Acad Sci USA.
93:7375–7380. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Milano CA, Allen LF, Rockman HA, Dolber
PC, McMinn TR, Chien KR, Johnson TD, Bond RA and Lefkowitz RJ:
Enhanced myocardial function in transgenic mice overexpressing the
beta-2-adrenergic receptor. Science. 264:582–586. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Engelhardt S, Hein L, Wiesmann F and Lohse
MJ: Progressive hypertrophy and heart failure in beta1-adrenergic
receptor transgenic mice. Proc Natl Acad Sci USA. 96:7059–7064.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Iwase M, Bishop SP, Uechi M, Vatner DE,
Shannon RP, Kudej RK, Wight DC, Wagner TE, Ishikawa Y, Homcy CK and
Vatner SF: Adverse effects of chronic endogenous sympathetic drive
induced by cardiac GS alpha overexpression. Circ Res. 78:517–524.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Antos CL, Frey N, Marx SO, Reiken S,
Gaburjakova M, Richardson JA, Marks AR and Olson EN: Dilated
cardiomyopathy and sudden death resulting from constitutive
activation of protein kinase a. Circ Res. 89:997–1004. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nichtova Z, Novotova M, Kralova E and
Stankovicova T: Morphological and functional characteristics of
models of experimental myocardial injury induced by isoproterenol.
Gen Physiol Biophys. 31:141–151. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chang SC, Ren S, Rau CD and Wang JJ:
Isoproterenol-induced heart failure mouse model using osmotic pump
implantation. Methods Mol Biol. 1816:207–220. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tan Y, Li Y, Xiao J, Shao H, Ding C,
Arteel GE, Webster KA, Yan J, Yu H, Cai L and Li X: A novel CXCR4
antagonist derived from human SDF-1beta enhances angiogenesis in
ischaemic mice. Cardiovasc Res. 82:513–521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu M, Zhou J, Cheng M, Boriboun C,
Biyashev D, Wang H, Mackie A, Thorne T, Chou J, Wu Y, et al: E2F1
suppresses cardiac neovascularization by down-regulating VEGF and
PlGF expression. Cardiovasc Res. 104:412–422. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kuznetsov AV, Javadov S, Sickinger S,
Frotschnig S and Grimm M: H9c2 and HL-1 cells demonstrate distinct
features of energy metabolism, mitochondrial function and
sensitivity to hypoxia-reoxygenation. Biochim Biophys Acta.
1853:276–284. 2015. View Article : Google Scholar :
|
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta DeltaC(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
43
|
Cheng M, Yang J, Zhao X, Zhang E, Zeng Q,
Yu Y, Yang L, Wu B, Yi G, Mao X, et al: Circulating myocardial
microRNAs from infarcted hearts are carried in exosomes and
mobilise bone marrow progenitor cells. Nat Commun. 10:9592019.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nie Y, Han YC and Zou YR: CXCR4 is
required for the quiescence of primitive hematopoietic cells. J Exp
Med. 205:777–783. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang ER, Jarrah AA, Benard L, Chen J,
Schwarzkopf M, Hadri L and Tarzami ST: Deletion of CXCR4 in
cardiomyocytes exacerbates cardiac dysfunction following
isoproterenol administration. Gene Ther. 21:496–506. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bresnick AR and Backer JM: PI3Kβ-A
versatile transducer for GPCR, RTK, and small GTPase signaling.
Endocrinology. 160:536–555. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ,
Kobilka BK and Xiao RP: Dual modulation of cell survival and cell
death by beta(2)-adrenergic signaling in adult mouse cardiac
myocytes. Proc Natl Acad Sci USA. 98:1607–1612. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang XX, Zhang FR, Zhu JH, Xie XD and Chen
JZ: Up-regulation of CXC chemokine receptor 4 expression in chronic
atrial fibrillation patients with mitral valve disease may be
attenuated by renin-angiotensin system blockers. J Int Med Res.
37:1145–1151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu X, Zeng Y, Liu Z, Li W, Wang L and Wu
M: Bioinformatics analysis of the circRNA-miRNA-mRNA network for
atrial fibrillation. Medicine (Baltimore). 101:e302212022.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang YF, Meng LB, Hao ML, Li XY and Zou
T: CXCR4 and TYROBP mediate the development of atrial fibrillation
via inflammation. J Cell Mol Med. 26:3557–3567. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang J, Huang X, Wang X, Gao Y, Liu L, Li
Z, Chen X, Zeng J, Ye Z and Li G: Identification of potential
crucial genes in atrial fibrillation: A bioinformatic analysis. BMC
Med Genomics. 13:1042020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu P, Sun H, Zhou X, Wang Q, Gao F, Fu Y,
Li T, Wang Y, Li Y, Fan B, et al: CXCL12/CXCR4 axis as a key
mediator in atrial fibrillation via bioinformatics analysis and
functional identification. Cell Death Dis. 12:8132021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Agarwal U, Ghalayini W, Dong F, Weber K,
Zou YR, Rabbany SY, Rafii S and Penn MS: Role of cardiac myocyte
CXCR4 expression in development and left ventricular remodeling
after acute myocardial infarction. Circ Res. 107:667–676. 2010.
View Article : Google Scholar : PubMed/NCBI
|
